Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
LV003 2nd Generation pLenti Combo Mix ABM Goods 200ul 224.7 LV003 2nd Generation pLenti Combo Mix ABM Goods 200ul 224.7 Publication
RA-4 Total Oxidant Status (TOS) RelAssay 200assays 860 RA-4 Total Oxidant Status (TOS) RelAssay 200assays 860
ASK
Publication
4520-096-K PARP in vivo Pharmacodynamic Assay 2nd Generation Trevigen 96 Samples 1269 4520-096-K PARP in vivo Pharmacodynamic Assay 2nd Generation Trevigen 96 Samples 1269 Publication
200100 pOET sequencing primers OET 2 x 100 176.841 200100 pOET sequencing primers OET 2 x 100 176.841
ASK
Publication
K-1010 AccuPower DNA Sequencing Kit 0.5 ml tubes Bioneer 25 reactions 203 K-1010 AccuPower DNA Sequencing Kit 0.5 ml tubes Bioneer 25 reactions 203
ASK
Publication
K-1010-1 AccuPower DNA Sequencing Kit 0.2 ml thin wall 8 strip tubes Bioneer 24 reactions 203 K-1010-1 AccuPower DNA Sequencing Kit 0.2 ml thin wall 8 strip tubes Bioneer 24 reactions 203
ASK
Publication
LC482 Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status US Biomax 160 LC482 Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status US Biomax 160
ASK
Publication
K-1020 TopTM DNA Sequencing Kit Solution Type 0.2 ml thin wall 8 strip tubes Bioneer 100 reactions 307 K-1020 TopTM DNA Sequencing Kit Solution Type 0.2 ml thin wall 8 strip tubes Bioneer 100 reactions 307
ASK
Publication
K-1020-1 TopTM DNA Sequencing Kit Solution Type 0.2 ml thin wall 8 strip tubes Bioneer 500 reactions 1074 K-1020-1 TopTM DNA Sequencing Kit Solution Type 0.2 ml thin wall 8 strip tubes Bioneer 500 reactions 1074
ASK
Publication
M1471 5 Carboxy X Rhodamine, NHS Ester, This dye is commonly used in dye terminator sequencing methods by attachment to dideoxynucleotide triphosphates (ddNTP's). It can also be used in other DNA or RNA lab MarkerGene 388 M1471 5 Carboxy X Rhodamine, NHS Ester, This dye is commonly used in dye terminator sequencing methods by attachment to dideoxynucleotide triphosphates (ddNTP's). It can also be used in other DNA or RNA lab MarkerGene 388
ASK
Publication
E0131p ELISA p55,p60,Pig,Sus scrofa,TNFR1,TNF-R1,TNF-RI,TNFR-I,TNFRSF1A,Tumor necrosis factor receptor 1,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor type I EIAab 96T 942 E0131p ELISA p55,p60,Pig,Sus scrofa,TNFR1,TNF-R1,TNF-RI,TNFR-I,TNFRSF1A,Tumor necrosis factor receptor 1,Tumor necrosis factor receptor superfamily member 1A,Tumor necrosis factor receptor type I EIAab 96T 942 Publication
BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804 US Biomax 231 BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores, replaced by BR804 US Biomax 231
ASK
Publication
BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores US Biomax 231 BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores US Biomax 231
ASK
Publication
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266
ASK
Publication
18-272-195121 TNFRSF1B - Goat polyclonal to TNFRSF1B; Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept Polyclonal GenWay 0.1 mg 428 18-272-195121 TNFRSF1B - Goat polyclonal to TNFRSF1B; Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept Polyclonal GenWay 0.1 mg 428
ASK
Publication
228-11542-1 Recombinant Human Tumor Protein D52 L1 Ray Biotech 10 201 228-11542-1 Recombinant Human Tumor Protein D52 L1 Ray Biotech 10 201 Publication
300-18 Rat Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 5ug 113.4 300-18 Rat Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
200-31 Mouse Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 5ug 113.4 200-31 Mouse Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
BC23011 Testis tumor combination, 24 cases 72 cores US Biomax 231 BC23011 Testis tumor combination, 24 cases 72 cores US Biomax 231
ASK
Publication
E0133h Human Tumor necrosis factor α ELISA Kit EIAab 96T 706 E0133h Human Tumor necrosis factor α ELISA Kit EIAab 96T 706 Publication
LF-P0079 Tumor necrosis factor (TNF-alpha) antigen ACR 20 309 LF-P0079 Tumor necrosis factor (TNF-alpha) antigen ACR 20 309 Publication
R1235218A-10 Total RNA - Human Tumor Tissue Melanoma Biochain 10 290 R1235218A-10 Total RNA - Human Tumor Tissue Melanoma Biochain 10 290 Publication
100-111 Human Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 10ug 113.4 100-111 Human Tumor Necrosis Factor alpha TNF-α Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
AG801 Adrenal tumor tissue array, 80 cases 80 cores US Biomax 266 AG801 Adrenal tumor tissue array, 80 cases 80 cores US Biomax 266
ASK
Publication
BC23012 Testis tumor tissue array, 23 cases 63 cores US Biomax 231 BC23012 Testis tumor tissue array, 23 cases 63 cores US Biomax 231
ASK
Publication
EN801 Endocrine tumor tissue array, 40 cases 80 cores. US Biomax 266 EN801 Endocrine tumor tissue array, 40 cases 80 cores. US Biomax 266
ASK
Publication
LY1501 Lymphoma tumor tissue array, 75 cases 150 cores US Biomax 380 LY1501 Lymphoma tumor tissue array, 75 cases 150 cores US Biomax 380
ASK
Publication
LY2086 Lymphoma tumor tissue array, 208 cases 208 cores US Biomax 633 LY2086 Lymphoma tumor tissue array, 208 cases 208 cores US Biomax 633
ASK
Publication
LY2088 Lymphoma tumor tissue array, 208 cases 208 cores US Biomax 558 LY2088 Lymphoma tumor tissue array, 208 cases 208 cores US Biomax 558
ASK
Publication
MTU481 Multiple tumor tissue array, 48 cases 48 cores US Biomax 142 MTU481 Multiple tumor tissue array, 48 cases 48 cores US Biomax 142
ASK
Publication
P1235218A Total Protein Human Tumor Tissue Melanoma Biochain 1 mg 386 P1235218A Total Protein Human Tumor Tissue Melanoma Biochain 1 mg 386 Publication
E90133Ca ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) Organism Dog USCNLife 96T/Kit 575.505 E90133Ca ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) Organism Dog USCNLife 96T/Kit 575.505 Publication
BC00113 Multiple organs tumor and normal tissue, 48 cases 48 cores US Biomax 189 BC00113 Multiple organs tumor and normal tissue, 48 cases 48 cores US Biomax 189
ASK
Publication
ER-14-1555 Goat Anti-Human Wilms tumor 1 WT1, (N Terminus) Antibodies Ray Biotech 100 μg 353 ER-14-1555 Goat Anti-Human Wilms tumor 1 WT1, (N Terminus) Antibodies Ray Biotech 100 μg 353
ASK
Publication
GIST481 Gastrointestinal stromal tumor tissue array, 24 cases 48 cores US Biomax 225 GIST481 Gastrointestinal stromal tumor tissue array, 24 cases 48 cores US Biomax 225
ASK
Publication
GL1002 Brain tumor and normal tissue array, 50 cases 100 cores US Biomax 266 GL1002 Brain tumor and normal tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
HL481 Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores US Biomax 231 HL481 Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores US Biomax 231
ASK
Publication
IRKTAH2622 Mouse Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit Innovative Research INC 1 kit(96 Wells) 597 IRKTAH2622 Mouse Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit Innovative Research INC 1 kit(96 Wells) 597 Publication
IRKTAH2628 Human Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit Innovative Research INC 1 kit(96 Wells) 597 IRKTAH2628 Human Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit Innovative Research INC 1 kit(96 Wells) 597
ASK
Publication
LY2084 Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores US Biomax 456 LY2084 Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores US Biomax 456
ASK
Publication
LY2085 Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores US Biomax 456 LY2085 Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores US Biomax 456
ASK
Publication
LY2087 Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores US Biomax 456 LY2087 Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores US Biomax 456
ASK
Publication
NHL483 Non Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores US Biomax 231 NHL483 Non Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores US Biomax 231
ASK
Publication
NST961 Nervous system tumor tissue array, 48 cases 96 cores US Biomax 225 NST961 Nervous system tumor tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
TE482 Testis tumor tissue array, including TNM, 24 cases 48 cores US Biomax 225 TE482 Testis tumor tissue array, including TNM, 24 cases 48 cores US Biomax 225
ASK
Publication
UV801 Vulva malignant tumor tissue array, 39 cases 78 cores US Biomax 266 UV801 Vulva malignant tumor tissue array, 39 cases 78 cores US Biomax 266
ASK
Publication
BO601 Bone giant cell tumor tissue array, 30 cases 60 cores US Biomax 231 BO601 Bone giant cell tumor tissue array, 30 cases 60 cores US Biomax 231
ASK
Publication
BR602 Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores US Biomax 0 BR602 Breast tumor and normal tissue array, with TNM data, 25 cases 60 cores US Biomax 0
ASK
Publication
GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases 80 cores US Biomax 231 GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases 80 cores US Biomax 231
ASK
Publication
GL1003 Brain tumor tissue array for antibody screening, 25 cases 100 cores US Biomax 266 GL1003 Brain tumor tissue array for antibody screening, 25 cases 100 cores US Biomax 266
ASK
Publication
Y050532 Anti DDC(Netrin receptor DCC precursor) (Tumor suppressor protein DCC) ABM Goods 100ug 437 Y050532 Anti DDC(Netrin receptor DCC precursor) (Tumor suppressor protein DCC) ABM Goods 100ug 437
ASK
Publication
BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores US Biomax 160 BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores US Biomax 160
ASK
Publication
BC21014 Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011 US Biomax 231 BC21014 Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011 US Biomax 231
ASK
Publication
bs-6983R Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody Sepax 100ug Lyophilized 222 bs-6983R Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody Sepax 100ug Lyophilized 222 Publication
CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases 208 cores US Biomax 456 GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases 208 cores US Biomax 456 GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases 72 cores US Biomax 266 GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases 72 cores US Biomax 266
ASK
Publication
GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases 80 cores US Biomax 266 GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases 80 cores US Biomax 266
ASK
Publication
MC501 Multiple organs tumor and matched adjacent tissue array, 27 cases 50 cores US Biomax 160 MC501 Multiple organs tumor and matched adjacent tissue array, 27 cases 50 cores US Biomax 160
ASK
Publication
RD172180100 Human, Complement C1q tumor necrosis factor protein 9 (CTRP9), E.coli , Rec. Prot. Biovendor 0.1 mg 352 RD172180100 Human, Complement C1q tumor necrosis factor protein 9 (CTRP9), E.coli , Rec. Prot. Biovendor 0.1 mg 352 Publication
T293 Bone marrow tumor and normal tissue array, including TNM, 6 cases 24 cores US Biomax 100 T293 Bone marrow tumor and normal tissue array, including TNM, 6 cases 24 cores US Biomax 100
ASK
Publication
Y050532 Anti-DDC(Netrin receptor DCC precursor) (Tumor suppressor protein DCC) Antibody ABM Goods 100ug 386 Y050532 Anti-DDC(Netrin receptor DCC precursor) (Tumor suppressor protein DCC) Antibody ABM Goods 100ug 386
ASK
Publication
BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456 BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456 CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
E90133Ca ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) Organism Canis familiaris; Canine (Dog) USCNLife 96T 714.42 E90133Ca ELISA Kit for Tumor Necrosis Factor Alpha (TNFa) Organism Canis familiaris; Canine (Dog) USCNLife 96T 714.42 Publication
MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores US Biomax 160 MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases 48 cores US Biomax 160
ASK
Publication
MC808 Multiple tumor tissue array 58 different tumors and their corresponding normal tissues with TNM data, 58 cases 96 cores US Biomax 266 MC808 Multiple tumor tissue array 58 different tumors and their corresponding normal tissues with TNM data, 58 cases 96 cores US Biomax 266
ASK
Publication
MCN601 Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602 US Biomax 231 MCN601 Multiple organ tumor and normal tissue array, 58 cases 60 cores, replaced by MCN602 US Biomax 231
ASK
Publication
bs-6983R-Cy3 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6983R-Cy3 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6983R-Cy5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6983R-Cy5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6983R-Cy5.5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6983R-Cy5.5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-6983R-Cy7 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 bs-6983R-Cy7 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6983R-HRP Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 bs-6983R-HRP Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 Publication
bs-6983R-PE-Cy5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6983R-PE-Cy5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 Publication
bs-6983R-PE-Cy5.5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6983R-PE-Cy5.5 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-6983R-PE-Cy7 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6983R-PE-Cy7 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 Publication
GL1921 Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores US Biomax 456 GL1921 Mid advanced stage brain tumor tissue array, including pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 US Biomax 266 GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 US Biomax 266
ASK
Publication
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
bs-6983R-Biotin Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Biotin conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6983R-Biotin Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Biotin conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6983R-FITC Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-6983R-FITC Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 Publication
CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266 FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266
ASK
Publication
HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266
ASK
Publication
LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456 MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516
ASK
Publication
MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231 MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores US Biomax 231
ASK
Publication
MNT241 Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores US Biomax 77 MNT241 Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores US Biomax 77
ASK
Publication
MTU241 Multiple tumor and normal tissue array, with 12 major types of cancer paired with matched NAT, 12 cases 24 cores US Biomax 166 MTU241 Multiple tumor and normal tissue array, with 12 major types of cancer paired with matched NAT, 12 cases 24 cores US Biomax 166
ASK
Publication
T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397
ASK
Publication
bs-6983R-A350 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6983R-A350 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6983R-A488 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6983R-A488 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6983R-A555 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6983R-A555 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6983R-A647 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6983R-A647 Rabbit Anti-WT-1 Wilms Tumor Protein Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
MTU951 Multiple tumor tissue array covering 40 types of all the common benign, malignant and metastatic entities, 40 cases 95 cores US Biomax 225 MTU951 Multiple tumor tissue array covering 40 types of all the common benign, malignant and metastatic entities, 40 cases 95 cores US Biomax 225
ASK
Publication
OV602 Tissue array of ovarian granulosa theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases 60 cores US Biomax 231 OV602 Tissue array of ovarian granulosa theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases 60 cores US Biomax 231
ASK
Publication
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266 BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266
ASK
Publication
LC991 Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores US Biomax 231 LC991 Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores US Biomax 231
ASK
Publication
MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634 MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634
ASK
Publication
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456
ASK
Publication
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394 FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266
ASK
Publication
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336
ASK
Publication
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277
ASK
Publication
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487
ASK
Publication
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231
ASK
Publication
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores US Biomax 160 BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores US Biomax 160
ASK
Publication
LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores US Biomax 456 LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores US Biomax 456
ASK
Publication
T323 Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88 T323 Spleen tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88
ASK
Publication
GL482 Brain tumor tissue array, with normal tissue, 48 cases 48 cores US Biomax 231 GL482 Brain tumor tissue array, with normal tissue, 48 cases 48 cores US Biomax 231
ASK
Publication
BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516 BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores US Biomax 266 BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases 100 cores US Biomax 266
ASK
Publication
GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores US Biomax 189 GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases 48 cores US Biomax 189
ASK
Publication
GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores US Biomax 266 GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases 80 cores US Biomax 266
ASK
Publication
HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266 HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores US Biomax 266 HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases 80 cores US Biomax 266
ASK
Publication
OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266 OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266 PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases 60 cores US Biomax 266
ASK
Publication
T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88 T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases 24 cores US Biomax 88
ASK
Publication
BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data US Biomax 189 BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases 48 cores with TNM data US Biomax 189
ASK
Publication
CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores US Biomax 231 CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores US Biomax 231
ASK
Publication
100-35 Human Tumor Necrosis Factor Receptor Type 1 TNF-Receptor-1 Shenandoah Biotechnology, Inc. 5ug 113.4 100-35 Human Tumor Necrosis Factor Receptor Type 1 TNF-Receptor-1 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
CMA241 Human tumor cell array, 12 cell lines 24 cores US Biomax 278 CMA241 Human tumor cell array, 12 cell lines 24 cores US Biomax 278
ASK
Publication
SFT961 Soft tissue tumor tissue array, 48 cases 96 cores US Biomax 225 SFT961 Soft tissue tumor tissue array, 48 cases 96 cores US Biomax 225
ASK
Publication
CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267 CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores US Biomax 231 CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases 80 cores US Biomax 231
ASK
Publication
BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456 BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases 208 cores US Biomax 456
ASK
Publication
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278 ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278
ASK
Publication
LC992 Lung adenocarcinoma (grade I III, 33 cases) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores US Biomax 231 LC992 Lung adenocarcinoma (grade I III, 33 cases) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores US Biomax 231
ASK
Publication
LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231 LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 231
ASK
Publication
OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456
ASK
Publication
SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T001 Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88 T001 Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores US Biomax 88
ASK
Publication
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88 T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88
ASK
Publication
T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T303 Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 T303 Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015 US Biomax 266 GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015 US Biomax 266
ASK
Publication
MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231 MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231
ASK
Publication
T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88 T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88
ASK
Publication
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278
ASK
Publication
FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278
ASK
Publication
FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278
ASK
Publication
FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278 FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278
ASK
Publication
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314 FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314
ASK
Publication
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380 FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380
ASK
Publication
OS208 High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases 208 cores US Biomax 456 OS208 High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases 208 cores US Biomax 456
ASK
Publication
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231 BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231
ASK
Publication
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634 MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634
ASK
Publication
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BC24011 Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231 BC24011 Soft tissue tumor (multi tissue combined panel) tissue array, 63 cases 63 cores US Biomax 231
ASK
Publication
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
GIST802 Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8 US Biomax 296 GIST802 Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8 US Biomax 296
ASK
Publication
T203 Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 cores US Biomax 88 T203 Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases 24 cores US Biomax 88
ASK
Publication
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811
ASK
Publication
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320
ASK
Publication
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90 T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88 T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases 24 cores US Biomax 88
ASK
Publication
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516 CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases 208 cores US Biomax 516
ASK
Publication
VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266 VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases 100 cores US Biomax 266
ASK
Publication
GL208 Brain primary tumor high density (69 cases 208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue US Biomax 456 GL208 Brain primary tumor high density (69 cases 208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue US Biomax 456
ASK
Publication
T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456 SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases 208 cores US Biomax 456
ASK
Publication
T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 US Biomax 231 CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 US Biomax 231
ASK
Publication
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90 T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105 T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88
ASK
Publication
188-01473 RANK Ligand Soluble, Human, recombinant  (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related ac B-Bridge 1 mg 0 188-01473 RANK Ligand Soluble, Human, recombinant  (RANKL) Receptor activator of nuclear factor kappa B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF related ac B-Bridge 1 mg 0
ASK
Publication
  Cat_Number Product name Supplier Quantity Price Tech More